AIWCX
Price
$12.67
Change
-$0.15 (-1.17%)
Updated
Nov 18 closing price
Net Assets
2.59B
RERBX
Price
$60.12
Change
-$0.82 (-1.35%)
Updated
Nov 18 closing price
Net Assets
134.2B
Interact to see
Advertisement

AIWCX vs RERBX

Header iconAIWCX vs RERBX Comparison
Open Charts AIWCX vs RERBXBanner chart's image
American Century International Gr C
Price$12.67
Change-$0.15 (-1.17%)
VolumeN/A
Net Assets2.59B
American Funds EUPAC R2
Price$60.12
Change-$0.82 (-1.35%)
VolumeN/A
Net Assets134.2B
AIWCX vs RERBX Comparison Chart in %
View a ticker or compare two or three
VS
AIWCX vs. RERBX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AIWCX is a Hold and RERBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 134B vs. AIWCX (2.59B). RERBX pays higher dividends than AIWCX: RERBX (0.23) vs AIWCX (0.00). AIWCX was incepted earlier than RERBX: AIWCX (24 years) vs RERBX (23 years). AIWCX (2.22) is less costly to investors than RERBX (1.56). AIWCX is a more actively managed with annual turnover of: 56.00 vs. RERBX (35.00). RERBX has a lower initial minimum investment than AIWCX: RERBX (250) vs AIWCX (2500). RERBX annual gain was more profitable for investors over the last year : 12.15 vs. AIWCX (11.48). RERBX return over 5 years is better than : 0.64 vs. AIWCX (-12.12).
AIWCXRERBXAIWCX / RERBX
Total Expense Ratio2.221.56142%
Annual Report Gross Expense Ratio2.221.56142%
Fund Existence24 years23 years-
Gain YTD11.96518.23066%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.59B134B2%
Annual Yield % from dividends0.000.23-
Returns for 1 year11.4812.1594%
Returns for 3 years26.1828.8391%
Returns for 5 years-12.120.64-1,908%
Returns for 10 years6.9832.6521%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HLGZX37.36N/A
N/A
Harding Loevner Global Equity Instl Z
DCCRX27.50N/A
N/A
Macquarie Small Cap Core R
SHPCX14.62N/A
N/A
Saratoga Health & Biotechnology C
OCMAX30.86N/A
N/A
OCM Gold Atlas
MUETX39.38-0.30
-0.76%
MFS Blended Research Core Equity R3